There were 1,671 press releases posted in the last 24 hours and 447,269 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image